Fate Therapeutics Inc (NASDAQ:FATE)
| 5.14 Delayed Data As of 4:00pm ET |  -0.28 / -5.17%Today’s Change | 4.02 Today|||52-Week Range 43.12 | -49.06% Year-to-Date |
Latest FATE News | Press Releases
No recent news for Fate Therapeutics Inc.
Today’s Trading
| Previous close | 5.42 |
| Today’s open | 5.42 |
| Day’s range | 5.13 - 5.47 |
| Volume | 164,418 |
| Average volume (3 months) | 3,317,411 |
| Market cap | $548.7M |
Data as of 4:00pm ET, 03/22/2023
Growth & Valuation
| Earnings growth (last year) | -29.95% |
| Earnings growth (this year) | +27.11% |
| Earnings growth (next 5 years) | +30.90% |
| Revenue growth (last year) | +72.44% |
| P/E ratio | NM |
| Price/Sales | 10.15 |
| Price/Book | 1.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AGENAgenus Inc | -0.13 | -7.98% |
| NVAXNovavax Inc | -0.24 | -3.99% |
| MORMorphoSys AG | -0.11 | -2.76% |
| ALECAlector Inc | -0.33 | -5.37% |
Data as of 4:00pm ET, 03/22/2023
Financials
| Next reporting date | May 3, 2023 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $96.3M |
| Annual profit (last year) | -$281.7M |
| Net profit margin | -292.55% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
